Robert Hershberg - Insider Trading & Ownership

Entity
Individual
Location
3005 First Avenue, Seattle, WA
Summary
The estimated net worth of Robert Hershberg is at least $17.8M dollars as of June 5, 2024. Robert Hershberg is the President and Chief Executive Officer, Director of HilleVax, Inc. and owns shares of HilleVax, Inc. (HLVX) stock worth about $16.8M. Robert Hershberg is the Director of RECURSION PHARMACEUTICALS, INC. and owns shares of RECURSION PHARMACEUTICALS, INC. (RXRX) stock worth about $454K. Robert Hershberg is the Director of Adaptive Biotechnologies Corp and owns shares of Adaptive Biotechnologies Corp (ADPT) stock worth about $368K. Robert Hershberg is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $109K. Robert Hershberg is the Director of NanoString Technologies Inc and owns shares of NS Wind Down Co., Inc. stock worth about $23.5K.
All Insider Reports
All Insider Reports

Ownership of Robert Hershberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HLVX HilleVax, Inc. President and Chief Executive Officer, Director $16.8M -$173K -1.02% Feb 8, 2024
RXRX RECURSION PHARMACEUTICALS, INC. Director $454K Jun 3, 2024
ADPT Adaptive Biotechnologies Corp Director $368K Mar 4, 2024
FATE FATE THERAPEUTICS INC Director $109K Jun 6, 2023
NSTG NS Wind Down Co., Inc. Director $23.5K Apr 18, 2022
SPRY ARS Pharmaceuticals, Inc. Director Jun 10, 2022

Insider Transactions Reported by Robert Hershberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.